BCYC included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding BCYC
8 latest ETF portfolios currently report this security. This page shows rows 1–8 of 8.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.468365% | 2021-07-30 | 2026-04-30 |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.360378% | 2026-02-28 | 2026-02-28 |
| MEDX | Horizon Kinetics Medical ETF | 0.337055% | Present before retained history; addition date unavailable | 2026-03-31 |
| SBIO | ALPS Medical Breakthroughs ETF | 0.184746% | 2026-02-28 | 2026-02-28 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.019586% | 2026-02-28 | 2026-02-28 |
| GWX | State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 0.017446% | 2026-03-31 | 2026-03-31 |
| IBB | iShares Biotechnology ETF | 0.013944% | 2026-03-31 | 2026-03-31 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 0.013346% | 2026-02-28 | 2026-02-28 |